Skip to main content
Moderna, Inc. logo

Moderna, Inc. — Investor Relations & Filings

Ticker · MRNA ISIN · US60770K1079 LEI · 549300EI6OKH5K5Q2G38 US Manufacturing
Open in API
Filings indexed 1,448 across all filing types
Latest filing 2018-12-07 Director's Dealing
Country US United States of America
Listing US MRNA

About Moderna, Inc.

https://www.modernatx.com/

Moderna, Inc. is a biotechnology company pioneering the development of messenger RNA (mRNA) therapeutics and vaccines. The company's core platform utilizes mRNA to carry instructions that direct the body's cells to produce proteins, thereby preventing or treating diseases. This technology enables the rapid design, research, and production of new medicines. Moderna is widely recognized for developing one of the first COVID-19 vaccines. Its research and development pipeline extends to various therapeutic areas, including infectious diseases, immuno-oncology, rare diseases, and autoimmune disorders. The company's mission is to create a new generation of transformative medicines for patients by leveraging the potential of its mRNA platform.

Recent filings

Filing Released Lang Actions
3 Filing
Director's Dealing
2018-12-07 English
3 Filing
Director's Dealing
2018-12-07 English
3 Filing
Director's Dealing
2018-12-07 English
3 Filing
Director's Dealing
2018-12-07 English
S-1/A Filing
Capital/Financing Update Classification · 95% confidence The document is a Form S-1 Registration Statement filed with the SEC by Moderna, Inc. It is an initial public offering (IPO) prospectus, containing detailed information about the company, its business, financial data, risk factors, management, and underwriting details. The document is not a financial report like an annual or quarterly report, nor is it an earnings release or a regulatory filing of a different nature. It is a registration statement for securities offering under the Securities Act of 1933, which fits the category of Capital/Financing Update (CAP) as it relates to company fundraising and capital structure changes through an IPO.
2018-12-04 English
S-1/A Filing
Regulatory Filings Classification · 100% confidence The document is a Form S-1 Registration Statement Amendment No. 1 filed with the SEC by Moderna, Inc. This form is used for registering securities for an initial public offering (IPO). The text includes detailed information about the offering, company overview, risk factors, management, executive compensation, underwriting, and other sections typical of a prospectus for an IPO. It is not an annual report, earnings release, or any other financial report but a registration statement for securities offering. According to the filing definitions, this type of document is best classified under Regulatory Filings (RNS) as it is a regulatory submission related to securities registration and does not fit into other specific categories like capital/financing update or proxy solicitation. The document length is substantial and contains detailed information, not just an announcement or certification, but the nature of the document is a regulatory filing for securities registration.
2018-11-28 English

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.